CN Patent
CN102875634B — 2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯的几种晶型
Assigned to Suzhou Pengxu Pharmatech Co ltd · Expires 2014-08-20 · 12y expired
What this patent protects
本发明涉及药物化学领域,具体涉及2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯的适应药物开发的几种晶型。其特征是它们是2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯的单甲醇合物、无水合物和管道二水合物。本发明的晶型比现有的晶型溶解度好,生物利用度高,稳定且低毒。
USPTO Abstract
本发明涉及药物化学领域,具体涉及2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯的适应药物开发的几种晶型。其特征是它们是2-氰基-3,12-二氧代齐墩果-1,9(11)-二烯-28-酸甲酯的单甲醇合物、无水合物和管道二水合物。本发明的晶型比现有的晶型溶解度好,生物利用度高,稳定且低毒。
Drugs covered by this patent
- Skyclarys (OMAVELOXOLONE) · Biogen Us
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.